Unlocking Fertility Insights:
The Power of AMH in Reproductive Health
Wednesday, September 24, 2025, 1:00 PM–2:00 PM ET
Webinar presenters Wendy Vitek, MD, Board-certified Reproductive Endocrinologist,
Boston IVF’s Syracuse, NY Fertility Center, and Shirley Li, MD, PhD, Associate Professor-Clinical, Department of Pathology; Director of Clinical Pathology Services and Co-Director of the Clinical Chemistry & Toxicology Laboratory, The Ohio State University, explore Anti-Müllerian Hormone (AMH) from both analytical and clinical perspectives. Gain insights into assay performance, method comparisons, and the practical utility of AMH in reproductive health and infertility treatment.
What will will you learn from this webinar?
- Discover why ovarian reserve testing is more important than ever, and how
Siemens Healthineers’ AMH assay supports timely, informed fertility decisions - Hear directly from a fertility specialist as to how AMH testing supports IVF
decisions and improves patient management - See how Siemens Healthineers’ AMH assay compares to other platforms and why its performance makes it a strong choice from the laboratory and patient management perspectives
- Ask questions of our distinguished presenters
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Siemens.
Advances in AML Series
Tuesday, October 28, 2025, 12:00 PM–1:00 PM ET
Webinar presenter Sanam Loghavi, MD, Associate Professor, Dept. of Hematopathology Division of Pathology/Lab Medicine, MD Anderson Cancer Center, presents from a Pathologist’s perspective, this program will allow you to learn and understand the following:
• Prevalence and severity of the FLT3-ITD mutation in AML
• Role of pathology in FLT3 mutation detection
• Patient identification and treatment landscape
What will this webinar empower you to do?
- Identify FLT3-ITD as a driver mutation in AML
- Understand its association with high relapse risk and poor survival outcomes
- Recognize the evolving treatment landscape
- Apply current testing and treatment guidelines to inform diagnostic practice
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. ©2025 Daiichi Sankyo, Inc. All rights reserved. PP-US-QZ-0370 08/25